IL17A and cancer: In addition, cancer susceptibility 2 (CASC2) [56] and cancer susceptibility 19 (CASC19) [57] have been demonstrated to exhibit proinflammatory and proapoptotic effects by regulating IL-17 and the miR-152-3p/DDX6 axis, respectively.